Angel One - Share Market Trading and Stock Broking
Open Demat AccountLogin

Biogen Inc.

Equity-NMS: BIIB

Healthcare | Drug Manufacturers - General

$181.46-1.95 (March 23, 2026)

Biogen Inc. Chart

Biogen Inc. Performance

Days Range

Previous Close: $183.41
Open: $183.13
EPS(TTM): 8.79
Shares O/S: 146.76 M
Day's Range$180.47 - $183.69
52W Range$110.04 - $202.41
Market Cap26.63 B

About Biogen Inc.

Biogen Inc. is a global biopharmaceutical company. The Company is focused on discovering, developing, and delivering advanced therapies for people living with serious and complex diseases worldwide. It operates a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and amyotrophic lateral sclerosis (ALS). It is focused on advancing its pipeline in neurology, specialized immunology, and rare diseases. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA for the treatment of SMA; SKYCLARYS for the treatment of Friedreich's Ataxia; QALSODY for the treatment of ALS, and FUMADERM for the treatment of severe plaque psoriasis. It also collaborations with Eisai on the commercialization of LEQEMBI for the treatment of Alzheimer's disease and Sage on the commercialization of ZURZUVAE for the treatment of Postpartum Depression (PPD).

Other Popular Stocks

Agilent Technologies Inc.

AbbVie Inc

AbCellera Biologics Inc

Abbott Laboratories

Aurora Cannabis Inc

Alcon AG

Align Technology Inc.

Alnylam Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

Amgen Inc.

Amneal Pharmaceuticals Inc.

American Well Corporation

Aphria Inc

Arcturus Therapeutics Holdings Inc

Arena Pharmaceuticals, Inc.

Axsome Therapeutics, Inc.

ASTRAZENECA PLC

Baxter International Inc.

Becton, Dickinson and Company

Beam Therapeutics Inc

Frequently Asked Questions

Biogen Inc. (BIIB) share price as of March 23, 2026 is $181.46. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Biogen Inc. (BIIB) Share by opening an international trading account with Angel One.
Purchasing Biogen Inc. (BIIB) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Biogen Inc. (BIIB) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Biogen Inc. (BIIB) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Biogen Inc. on February 11, 2026, is $26.63 B.
Biogen Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
In order to invest in Biogen Inc. (BIIB) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Open Free Demat Account!
Join our 3.5 Cr+ happy customers